Biotoxtech Co Ltd
KOSDAQ:086040
Biotoxtech Co Ltd
Research & Development
Biotoxtech Co Ltd
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
Biotoxtech Co Ltd
KOSDAQ:086040
|
Research & Development
-₩546.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-33%
|
|
|
Samsung Biologics Co Ltd
KRX:207940
|
Research & Development
-₩173.8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-176%
|
CAGR 10-Years
N/A
|
|
|
P
|
Peptron Inc
KOSDAQ:087010
|
Research & Development
-₩15.8B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-24%
|
|
|
S
|
ST Pharm Co Ltd
KOSDAQ:237690
|
Research & Development
-₩20.9B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
F
|
FutureChem Co Ltd
KOSDAQ:220100
|
Research & Development
-₩4.3B
|
CAGR 3-Years
4%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
|
|
L
|
LegoChem Biosciences Inc
KOSDAQ:141080
|
Research & Development
-₩171.1B
|
CAGR 3-Years
-72%
|
CAGR 5-Years
-51%
|
CAGR 10-Years
-36%
|
|
Biotoxtech Co Ltd
Glance View
Biotoxtech Co., Ltd. engages in the provision of non-clinical drug trials. The company is headquartered in Cheongju, Chungcheongbuk-Do. The company went IPO on 2007-09-21. The firm provides safety evaluation research, efficacy evaluation research and analysis research. Its safety evaluation research business provides general toxicity tests, local toxicity tests, reproductive and development tests, genotoxicity tests, immunotoxicity tests, carcinogenicity tests, safety pharmacology tests, ecotoxicology tests, histopathology tests and hematology tests. Its efficacy evaluation research business provides efficacy evaluation of medical supplies, health supplements and cosmetics. Its analysis research business provides pharmacokinetics (PK) tests and toxicokinetics (TK) tests services, as well as validation and bio analysis services. On March 13, 2013, the Company acquired a 60% stake in its new established subsidiary.
See Also
What is Biotoxtech Co Ltd's Research & Development?
Research & Development
-546.2m
KRW
Based on the financial report for Sep 30, 2025, Biotoxtech Co Ltd's Research & Development amounts to -546.2m KRW.
What is Biotoxtech Co Ltd's Research & Development growth rate?
Research & Development CAGR 10Y
-33%
Over the last year, the Research & Development growth was 37%.
